Related Experiment Video
Updated: Jul 6, 2025

07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.0K
Development of Platinum Complexes for Tumor Chemoimmunotherapy
Suxing Jin1,2, Yan Guo3, Xiaoyong Wang2
1School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, 210023, P. R. China.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|January 3, 2024
Summary
Platinum complexes enhance cancer treatment by combining chemotherapy with immunotherapy. These platinum compounds not only kill tumor cells but also modulate the immune system, improving drug resistance and reducing toxicity.
Area of Science:
- Oncology
- Immunology
- Medicinal Chemistry
Background:
- Platinum complexes are established chemotherapy agents.
- Emerging evidence highlights their immunomodulatory roles in antitumor activity.
- Combining chemotherapy with immunotherapy offers enhanced therapeutic potential.
Purpose of the Study:
- To review the concept of chemoimmunotherapy.
- To summarize recent advancements of platinum complexes as chemoimmunotherapeutic agents.
- To explore the multifaceted roles of platinum complexes in cancer treatment.
Main Methods:
- Literature review of chemoimmunotherapy and platinum complexes.
- Analysis of platinum complexes' mechanisms in inducing immunogenic cell death.
- Examination of platinum complexes' roles in immune checkpoint blockade and immune signaling modulation.
Main Results:
- Platinum complexes exhibit both cytotoxic and immunomodulatory effects.
- They can be developed as inducers of immunogenic cell death.
- Platinum complexes act as immune checkpoint blockers and regulators of the tumor immune microenvironment.
Conclusions:
- Synergistic chemoimmunotherapy with platinum complexes enhances antitumor activity.
- This approach helps overcome drug resistance and systemic toxicity.
- Platinum complexes offer new avenues for developing metal-based anticancer drugs.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

